Rhumbline Advisers Sells 9,956 Shares of AdaptHealth Corp. $AHCO

Rhumbline Advisers trimmed its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 3.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 303,154 shares of the company’s stock after selling 9,956 shares during the quarter. Rhumbline Advisers owned about 0.22% of AdaptHealth worth $3,286,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the company. Strs Ohio bought a new position in AdaptHealth in the 1st quarter valued at about $695,000. Intech Investment Management LLC increased its holdings in AdaptHealth by 88.8% in the 1st quarter. Intech Investment Management LLC now owns 225,452 shares of the company’s stock valued at $2,444,000 after buying an additional 106,035 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in AdaptHealth by 18.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 233,780 shares of the company’s stock valued at $2,534,000 after buying an additional 35,879 shares during the period. Woodline Partners LP bought a new position in AdaptHealth in the 1st quarter valued at about $2,851,000. Finally, Empowered Funds LLC increased its holdings in AdaptHealth by 2.0% in the 1st quarter. Empowered Funds LLC now owns 728,266 shares of the company’s stock valued at $7,894,000 after buying an additional 14,623 shares during the period. 82.67% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other AdaptHealth news, Director David Solomon Williams III sold 8,200 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $9.73, for a total value of $79,786.00. Following the sale, the director owned 50,045 shares in the company, valued at $486,937.85. This trade represents a 14.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 1.55% of the stock is owned by corporate insiders.

AdaptHealth Stock Performance

Shares of AdaptHealth stock opened at $9.11 on Tuesday. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.70. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.06 and a quick ratio of 0.82. The firm has a market capitalization of $1.23 billion, a P/E ratio of 16.87, a P/E/G ratio of 1.04 and a beta of 1.59. The company’s 50 day moving average price is $9.33 and its two-hundred day moving average price is $9.22.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of AdaptHealth from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. Five research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, AdaptHealth currently has a consensus rating of “Buy” and an average target price of $13.40.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.